Hiroaki Nabeka

535 total citations
38 papers, 426 citations indexed

About

Hiroaki Nabeka is a scholar working on Molecular Biology, Physiology and Cell Biology. According to data from OpenAlex, Hiroaki Nabeka has authored 38 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Physiology and 13 papers in Cell Biology. Recurrent topics in Hiroaki Nabeka's work include Lysosomal Storage Disorders Research (11 papers), Cellular transport and secretion (10 papers) and Neuroscience and Neuropharmacology Research (5 papers). Hiroaki Nabeka is often cited by papers focused on Lysosomal Storage Disorders Research (11 papers), Cellular transport and secretion (10 papers) and Neuroscience and Neuropharmacology Research (5 papers). Hiroaki Nabeka collaborates with scholars based in Japan, Bangladesh and China. Hiroaki Nabeka's co-authors include Seiji Matsuda, Tetsuya Shimokawa, Shouichiro Saito, Naoto Kobayashi, Sakirul Khan, Huiling Gao, Hiroyuki Wakisaka, Zhan‐You Wang, Mamun Al Mahtab and Yaming Cao and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Neuroscience.

In The Last Decade

Hiroaki Nabeka

38 papers receiving 403 citations

Peers

Hiroaki Nabeka
Annette M. Shadiack United States
J. L. Webb United States
Rajprasad Loganathan United States
Helen C. Miranda United States
Stanley Iyadurai United States
Todd J. Brown United States
Annette M. Shadiack United States
Hiroaki Nabeka
Citations per year, relative to Hiroaki Nabeka Hiroaki Nabeka (= 1×) peers Annette M. Shadiack

Countries citing papers authored by Hiroaki Nabeka

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Nabeka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Nabeka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Nabeka more than expected).

Fields of papers citing papers by Hiroaki Nabeka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Nabeka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Nabeka. The network helps show where Hiroaki Nabeka may publish in the future.

Co-authorship network of co-authors of Hiroaki Nabeka

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Nabeka. A scholar is included among the top collaborators of Hiroaki Nabeka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Nabeka. Hiroaki Nabeka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khan, Farzana, Sakirul Khan, Hiroaki Nabeka, et al.. (2023). Neurotoxic stimulation alters prosaposin levels in the salivary systems of rats. Cell and Tissue Research. 395(2). 159–169. 1 indexed citations
2.
Khan, Sakirul, Akihide Takeuchi, Hiroaki Nabeka, et al.. (2023). Administration of prosaposin-derived neurotrophic factor to neural tube defects facilitates regeneration and restores neurological functions. iScience. 26(4). 106277–106277. 5 indexed citations
3.
Khan, Sakirul, Hiroaki Nabeka, Tetsuya Shimokawa, et al.. (2022). A comprehensive design for prevention and management of COVID-19 in a tertiary medical institution in Bangladesh. The Journal of Infection in Developing Countries. 16(8). 1252–1257. 1 indexed citations
4.
Kubo, Shuichi, Akinori Tokunaga, Hiroaki Nabeka, et al.. (2021). Inhibition of low-density lipoprotein uptake by Helicobacter pylori virulence factor CagA. Biochemical and Biophysical Research Communications. 556. 192–198. 11 indexed citations
5.
Nabeka, Hiroaki, Sakirul Khan, Tetsuya Shimokawa, et al.. (2021). The expression of prosaposin and its receptors, GRP37 and GPR37L1, are increased in the developing dorsal root ganglion. PLoS ONE. 16(8). e0255958–e0255958. 10 indexed citations
6.
Nabeka, Hiroaki. (2021). Prosaposin, a neurotrophic factor, protects neurons against kainic acid-induced neurotoxicity. Anatomical Science International. 96(3). 359–369. 6 indexed citations
7.
Nabeka, Hiroaki, Hiroyuki Wakisaka, Kana Unuma, et al.. (2020). Prosaposin and its receptors GRP37 and GPR37L1 show increased immunoreactivity in the facial nucleus following facial nerve transection. PLoS ONE. 15(12). e0241315–e0241315. 13 indexed citations
8.
Khan, Sakirul, et al.. (2020). Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19. Archivos de Bronconeumología. 56(12). 828–830. 36 indexed citations
9.
Khan, Sakirul, et al.. (2020). Reply to “Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19”. Archivos de Bronconeumología. 57. 65–66. 1 indexed citations
10.
Shimokawa, Tetsuya, Hiroaki Nabeka, Sakirul Khan, et al.. (2020). Prosaposin in the rat oviductal epithelial cells. Cell and Tissue Research. 383(3). 1191–1202. 3 indexed citations
11.
Islam, Farzana, Sakirul Khan, Hiroaki Nabeka, et al.. (2018). Prosaposin and its receptors are differentially expressed in the salivary glands of male and female rats. Cell and Tissue Research. 373(2). 439–457. 6 indexed citations
12.
Li, Xuan, Hiroaki Nabeka, Shouichiro Saito, et al.. (2017). Expression of prosaposin and its receptors in the rat cerebellum after kainic acid injection. IBRO Reports. 2. 31–40. 17 indexed citations
13.
Nabeka, Hiroaki, Shouichiro Saito, Tetsuya Shimokawa, et al.. (2017). Interneurons secrete prosaposin, a neurotrophic factor, to attenuate kainic acid-induced neurotoxicity. IBRO Reports. 3. 17–32. 15 indexed citations
14.
Nabeka, Hiroaki, Tetsuya Shimokawa, Shouichiro Saito, et al.. (2015). A Prosaposin-Derived Peptide Alleviates Kainic Acid-Induced Brain Injury. PLoS ONE. 10(5). e0126856–e0126856. 17 indexed citations
15.
Nabeka, Hiroaki, Tetsuya Shimokawa, Cheng Li, et al.. (2014). Prosaposin Overexpression following Kainic Acid-Induced Neurotoxicity. PLoS ONE. 9(12). e110534–e110534. 21 indexed citations
16.
Li, Cheng, Hiroaki Nabeka, Tetsuya Shimokawa, et al.. (2013). Decrease in Prosaposin in the Dystrophic mdx Mouse Brain. PLoS ONE. 8(11). e80032–e80032. 15 indexed citations
17.
Li, Cheng, Huiling Gao, Tetsuya Shimokawa, et al.. (2013). Prosaposin expression in the regenerated muscles of mdx and cardiotoxin-treated mice.. PubMed. 28(7). 875–92. 14 indexed citations
18.
Saito, Shouichiro, Hiroaki Nabeka, Naohito Hato, et al.. (2012). Prosaposin-derived peptide alleviates ischaemia-induced hearing loss. Acta Oto-Laryngologica. 133(5). 462–468. 18 indexed citations
19.
Xue, Bing, Jie Chen, Huiling Gao, et al.. (2011). Chronological changes in prosaposin in the developing rat brain. Neuroscience Research. 71(1). 22–34. 6 indexed citations
20.
Zhang, Xuejiao, Li Cheng, Huiling Gao, et al.. (2011). Rho kinase inhibitors stimulate the migration of human cultured osteoblastic cells by regulating actomyosin activity. Cellular & Molecular Biology Letters. 16(2). 279–95. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026